China Healthwise Holdings Statistics
Want to see HK:0348 full AI Analyst Report?
China Healthwise Holdings (0348) Stock Statistics & Valuation Metrics
Total Valuation
China Healthwise Holdings has a market cap or net worth of HKD 67.49M. The enterprise value is HKD 115.06M.
- Market Cap
- HKD 67.49M
- Enterprise Value
- HKD 115.06M
Share Statistics
China Healthwise Holdings has 924,570,860 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 924,570,860
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
China Healthwise Holdings’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is -14.74%.
- Return on Equity (ROE)
- 0.07
- Return on Assets (ROA)
- -0.02
- Return on Invested Capital (ROIC)
- -14.74%
- Return on Capital Employed (ROCE)
- 0.69
- Revenue Per Employee
- 1.31M
- Profits Per Employee
- -34.29K
- Employee Count
- 76
- Asset Turnover
- 0.80
- Inventory Turnover
- 1.55
Valuation Ratios
The current PE Ratio of China Healthwise Holdings is -1.70. China Healthwise Holdings’s PEG ratio is 0.01.
- PE Ratio
- -1.70
- PS Ratio
- 0.55
- PB Ratio
- -1.12
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- 16.61
- PEG Ratio
- 0.01
Income Statement
In the last 12 months, China Healthwise Holdings had revenue of 99.56M and earned -2.61M in profits. Earnings per share was -0.00.
- Revenue
- 99.56M
- Gross Profit
- 37.20M
- Operating Income
- -12.67M
- Pretax Income
- -3.29M
- Net Income
- -2.61M
- EBITDA
- -6.26M
- Earnings Per Share (EPS)
- -0.00
Cash Flow
In the last 12 months, operating cash flow was 3.39M and capital expenditures -3.39M, giving a free cash flow of 0 billion.
- Operating Cash Flow
- 3.39M
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
China Healthwise Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- -58.88%
Stock Price Statistics
- Beta
- -0.11
- 52-Week Price Change
- -61.17%
- 50-Day Moving Average
- 0.07
- 200-Day Moving Average
- 0.08
- Relative Strength Index (RSI)
- 44.21
- Average Volume (3m)
- 470.39K
Important Dates
China Healthwise Holdings upcoming earnings date is Mar 29, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 27, 2026
- Next Earnings Date
- Mar 29, 2027
- Ex-Dividend Date
- ―
Financial Position
China Healthwise Holdings as a current ratio of 0.83, with Debt / Equity ratio of -275.72%
- Current Ratio
- 0.83
- Quick Ratio
- 0.55
- Debt to Market Cap
- 0.94
- Net Debt to EBITDA
- -15.48
- Interest Coverage Ratio
- -0.92
Taxes
In the past 12 months, China Healthwise Holdings has paid 686.00K in taxes.
- Income Tax
- 686.00K
- Effective Tax Rate
- -0.21
Enterprise Valuation
China Healthwise Holdings EV to EBITDA ratio is -5.13, with an EV/FCF ratio of 0.00.
- EV to Sales
- 1.38
- EV to EBITDA
- -5.13
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- 42.01
Balance Sheet
China Healthwise Holdings has HKD 22.69M in cash and marketable securities with HKD 94.61M in debt, giving a net cash position of -HKD 71.92M billion.
- Cash & Marketable Securities
- HKD 22.69M
- Total Debt
- HKD 94.61M
- Net Cash
- -HKD 71.92M
- Net Cash Per Share
- -HKD 0.08
- Tangible Book Value Per Share
- -HKD 0.07
Margins
Gross margin is 24.03%, with operating margin of -34.80%, and net profit margin of -32.09%.
- Gross Margin
- 24.03%
- Operating Margin
- -34.80%
- Pretax Margin
- -48.77%
- Net Profit Margin
- -32.09%
- EBITDA Margin
- -26.86%
- EBIT Margin
- -34.80%
Analyst Forecast
The average price target for China Healthwise Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- -18.07%
- EPS Growth Forecast
- -225.76%
Scores
- Smart Score
- 7
- AI Score
- 44

